Measles
📧 Sign up to get email alerts when something new happens for Measles.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-03-15Clinical Trial Update: Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED) [Phase 2]
Phase 2 trial results assessing the safety, tolerability, and immunogenicity of an investigational recombinant human albumin (rHA)–based vac…
-
CLINICAL_TRIALS trial_result · 2017-03-15Clinical Trial Update: A Measles, Mumps, and Rubella Investigational Vaccine Trial (V205C-010)(COMPLETED) [Phase 2]
This update reports the completion of a Phase 2 trial evaluating an investigational measles vaccine (V205C-010) sponsored by Merck Sharp & D…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Safety Study of a Refrigerator-stable Formulation of VARIVAX® [Phase 4]
The document reports the completion of a Phase 4 safety study of a refrigerator-stable formulation of VARIVAX (varicella vaccine) sponsored …
-
CLINICAL_TRIALS trial_result · 2017-01-31Clinical Trial Update: Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Special Drug Use Surveillance of Vaccinees After the First Vaccination
A completed Takeda-sponsored trial provides results from safety surveillance following the first vaccination with a freeze-dried live attenu…
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy Children [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of PriorixTetra when co-administered with a conjugated MenC vaccine in healthy children; …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-10-07Clinical Trial Update: Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™ [Phase 2]
Phase 2 study assessing immunogenicity and safety of a combined Measles-Mumps-Rubella-Varicella vaccine (MeMuRu-OKA) compared with Priorix (…
-
CLINICAL_TRIALS trial_result · 2016-10-07Clinical Trial Update: Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™ [Phase 2]
Phase 2 trial evaluating the immunogenicity and safety of the MeMuRu-OKA measles-mumps-rubella-varicella vaccine compared with Priorix given…
-
CLINICAL_TRIALS trial_result · 2016-09-26Clinical Trial Update: Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases [Phase 3]
Phase 3 trial evaluating the immunogenicity and safety of a combined measles, mumps, rubella, and varicella vaccine. The study has completed…
-
CLINICAL_TRIALS trial_result · 2016-09-21Clinical Trial Update: Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases [Phase 3]
A Phase 3 trial assessed the immunogenicity and safety of a combined measles, mumps, rubella and varicella vaccine (MMRV) developed by Glaxo…
-
CLINICAL_TRIALS trial_result · 2016-09-21Clinical Trial Update: Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases [Phase 4]
This Phase 4 trial update reports on the immunogenicity and safety of a combined measles, mumps, rubella, and varicella vaccine developed by…
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore. [Phase 4]
Phase 4 trial update evaluating GSK's MMR vaccine Priorix in healthy children aged 12 to 18 months in Singapore.
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine [Phase 3]
This document reports long-term immunogenicity and safety results from a Phase 3 trial of the MMRV vaccine, evaluating durability of immune …
-
CLINICAL_TRIALS trial_result · 2016-08-01Clinical Trial Update: Immunogenicity of Co-administration of Measles and Japanese Encephalitis Vaccines [Phase 4]
Phase 4 trial assessing immunogenicity when measles vaccine is co-administered with a Japanese encephalitis vaccine; the study has completed…
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months. [Phase 3]
Phase 3 trial evaluating immunogenicity, reactogenicity and safety of a combined Measles, Mumps and Rubella vaccine produced by Bio-Manguinh…
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presentations [Phase 4]
Phase 4 clinical trial comparing immunogenicity of single-dose versus multidose measles-mumps-rubella vaccine presentations completed.
-
CLINICAL_TRIALS trial_result · 2016-06-22Clinical Trial Update: Study to Evaluate Safety and Imunogenicity of Double Viral Vaccine (MR) for Measles and Rubella [Phase 1]
Phase 1 trial evaluating safety and immunogenicity of a measles-rubella double-antigen vaccine; the study sponsored by Bio-Manguinhos/Fiocru…
-
CLINICAL_TRIALS trial_result · 2016-03-18Clinical Trial Update: MMR and MMRV Vaccines: Effect of Age at First Dose on Safety and Immunogenicity of the Measles Component.
This clinical trial update investigates how the age at first dose influences safety and immunogenicity of the measles component in MMR and M…
-
CLINICAL_TRIALS trial_result · 2015-10-23Clinical Trial Update: A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED) [Phase 3]
This update reports the completion of a Phase 3 study evaluating Merck's Measles, Mumps, Rubella, and Varicella vaccine (ProQuad) in healthy…
-
CLINICAL_TRIALS trial_result · 2015-09-17Clinical Trial Update: MMR and Varicella Vaccine in Premature Infants
A completed clinical trial evaluating the MMR vaccine and the varicella vaccine in premature infants.
-
CLINICAL_TRIALS trial_result · 2015-05-29Clinical Trial Update: Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age [Phase 3]
A Phase 3 trial evaluating the DTap-IPV vaccine as the fifth dose in children aged 4 to 6 years, comparing it with DAPTACEL and IPOL; result…
-
CLINICAL_TRIALS trial_result · 2014-12-10Clinical Trial Update: Making Decisions About the Measles-Mumps-Rubella Vaccine [NA]
This clinical trial update discusses decisions about the Measles-Mumps-Rubella vaccine (MMR). The University of Michigan–sponsored study is …
-
CLINICAL_TRIALS trial_result · 2014-12-01Clinical Trial Update: A Clinical Trial to Assess the Safety of a Measles Vaccine (Dry Powder) Administered by Two Different Devices [Phase 1]
Phase 1 trial assessing the safety of a dry-powder measles vaccine delivered by two devices; study completed with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-09-18Clinical Trial Update: Immune Reconstitution to Measles Virus of HIV Infected Children in Zambia
A completed clinical trial sponsored by the University of North Carolina exploring immune reconstitution to measles virus in HIV-infected ch…
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers [Phase 3]
A Phase 3 trial in Taiwanese toddlers evaluated co-administration of a Japanese Encephalitis chimeric virus vaccine with a Measles-Mumps-Rub…
-
CLINICAL_TRIALS trial_result · 2014-07-02Clinical Trial Update: Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027) [Phase 3]
Phase 3 trial evaluating safety, tolerability, and immunogenicity of an alternative manufacturing process for MMRV vaccine (AMP) with comple…